Navigation Links
Michigan-Based Stryker Corp. and Its Howmedica Osteonics Subsidiary Are Targeted in Defective Hip Implant Lawsuit
Date:9/13/2013

Southfield, Michigan (PRWEB) September 13, 2013

Like thousands of other patients with debilitating hip pain, Arthur Curnow sought appropriate medical treatment, took his physician’s advice, and underwent two successive surgeries in 2010 to replace his right and left hips. Then things got worse.

According to court documents in a case recently filed in Macomb County Circuit Court (Number 2013-001999-NP), both hip implant devices – manufactured by Stryker Corporation and its wholly-owned subsidiary Howmedica Osteonics, and sold under “The Rejuvenate® System” product name – failed. Specifically, the metal surfaces in each device’s neck and stem began to rub against one another, causing metallic debris to shed, causing damage to the surrounding tissues. Blood tests revealed the presence of heavy metal ion contamination, and MRI results showed fluid collections around the hip implant. Eventually, his physician recommended revision surgeries to remove both Rejuvenate devices. At surgery, the damage caused by the metal debris was clearly visible.

“Both Mr. Curnow and his doctor trusted that Stryker and Howmedica had properly researched, tested, and marketed the Rejuvenate System,” says Robert B. Sickels, an attorney at Sommers Schwartz, P.C. who represents Arthur Curnow and his wife in a lawsuit recently filed in Macomb County Circuit Court (Case Number 2013-001999-NP). “As we now know from the recall of the product, Rejuvenate simply wasn’t safe and people were seriously injured.”

Approved for sale in the U.S. in 2008, the Rejuvenate device was implanted in an estimated 20,000 patients before Stryker issued a recall in July 2012 that also included its ABG II product, another modular stem design. Typically, hip implants are expected to last 15 to 20 years, but many Rejuvenate patients have suffered failures within two to five years after implantation.

“The most significant risk inherent in the Rejuvenate device is metallosis,” says Mr. Sickels, who has represented numerous patients in lawsuits against hip implant manufacturers and is himself a double hip implant recipient. “The tissue in your body can often react quite adversely to heavy metals, causing pain, limited mobility, hip joint failure, and disintegration of surrounding tissues and bone – all of which Mr. Curnow experienced. Many implant patients will be harmed for life.”

______________________________________________

Sommers Schwartz, P.C., a law firm located in Southfield, Michigan, represents individuals in Michigan and across the country who have been harmed as a result of medical errors, defective products, loss of employment, and other forms of negligence or intentional injury, as well as businesses involved in complex litigation matters that jeopardize their existence. Additional information about Sommers Schwartz can be found on its website: http://www.sommerspc.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11120426.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Stryker Hip Implant News: Rottenstein Law Group LLP Applauds Consumer Reports’ Call for Metal-on-Metal Hip Manufacturer Accountability
2. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Conferences in State, Federal Stryker Hip Recall Litigations
3. The FDA Issues Class 1 Recall for Stryker’s Oasys Midline Occiput Plate Due to a Key Defect, Reports Parker Waichman LLP
4. Stryker Hip Lawsuit News: Wright & Schulte LLC Commend Mediation Plan in New Jersey Stryker Hip Replacement Lawsuits
5. Stryker Hip Lawsuit Update: Bernstein Liebhard LLP Notes Additional Progress in Stryker Hip Recall Litigation Underway in New Jersey Superior Court
6. Stryker Hip Replacement Recall Lawyers at Wright & Schulte LLC Report on Growing Number of Stryker Hip Replacement Lawsuits
7. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of New Case Management Order in New Jersey Stryker Recall Litigation
8. Kershaw, Cutter & Ratinoff Launches Legal YouTube Video Blog to Assist Stryker Rejuvenate Recall Victims Nationwide
9. Stryker Lawsuits Move Forward in New Jersey Superior Court, as Bernstein Liebhard LLP Notes Upcoming Case Management Conference
10. Stryker Hip Lawsuit News: Bernstein Liebhard LLP Notes Issuance of Protective Order in New Jersey Stryker Hip Recall Litigation
11. Stryker Hip Lawsuits Proceed in New Jersey Litigation as Court Issues New Case Orders, Reports Wright & Schulte
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... Slidell, Louisiana (PRWEB) , ... April 29, 2017 ... ... and Brookshire’s Grocery Company to the list of fine retailers selling biodegradable, hanging ... company. H.E.B., a large supermarket chain headquartered in San Antonio, Texas, operates ...
(Date:4/28/2017)... Washington, DC (PRWEB) , ... April 28, 2017 ... ... Unplanned Pregnancy (The National Campaign) announces its support for the Access to ... by Sen. Jeanne Shaheen (D-NH) and Rep. Jackie Speier (D-CA), will help to ...
(Date:4/28/2017)... ... April 28, 2017 , ... Beginning in 2017, Ridgecrest Herbals will be phasing ... the popular ClearLungs Extra Strength formula. To ensure that the effectiveness of Clear Lungs ... ways:, , Removal of the homeopathic element , ...
(Date:4/28/2017)... ... April 28, 2017 , ... Date aired: ... , “Computers are everywhere and they’re here to stay,” said Sharon Kleyne on ... and Your Health on Voice America sponsored by Nature’s Tears® EyeMist®. So she ...
(Date:4/28/2017)... ... April 28, 2017 , ... Children and adolescents who ... experiences than children in the general population. That’s because foster care is designed ... family challenges. While no fault of their own, youth who have experienced trauma ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  Vanderbilt University Medical ... patients in Nashville , Tennesse have ... Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. The ... provide long-term reflux control by restoring normal function to ... 65 million people in the United States ...
(Date:4/19/2017)... SAN DIEGO , April 19, 2017 /PRNewswire/ ... ("Sorrento"), an antibody-centric, clinical-stage biopharmaceutical company developing new ... today announced the closing of its previously announced ... common stock at a public offering price of ... commissions and estimated offering expenses payable by Sorrento.  ...
(Date:4/19/2017)... April 19, 2017  New research provides evidence that an ... according to a study released today that will be presented ... in Boston , April 22 to ... treatment of Parkinson,s disease, the oral drug levodopa has long ... longevity. But as the disease progresses, the effects of the ...
Breaking Medicine Technology: